Kuo DY - Search Results

1

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study.

Kuo DY, Blank SV, Christos PJ, Kim M, Caputo TA, Pothuri B, Hershman D, Goldman N, Ivy PS, Runowicz CD, Muggia F, Goldberg GL, Einstein MH. Kuo DY, et al. Gynecol Oncol. 2010 Mar;116(3):442-6. doi: 10.1016/j.ygyno.2009.10.082. Epub 2009 Nov 20. Gynecol Oncol. 2010. PMID: 19931137 Free PMC article. Clinical Trial.

2

Screening of cervical cancer: where do we go from here?

Kuo DY, Goldberg GL. Kuo DY, et al. Cancer Invest. 2003;21(1):157-61. doi: 10.1081/cnv-120016410. Cancer Invest. 2003. PMID: 12643017 Review. No abstract available.

3

A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers.

Gupta D, Owers RL, Kim M, Kuo DY, Huang GS, Shahabi S, Goldberg GL, Einstein MH. Gupta D, et al. Among authors: kuo dy. Gynecol Oncol. 2009 Jun;113(3):327-30. doi: 10.1016/j.ygyno.2009.02.018. Gynecol Oncol. 2009. PMID: 19307014 Free PMC article. Clinical Trial.

4

Intravenous leiomyomatosis with intracardiac extension: a single-institution experience.

Worley MJ Jr, Aelion A, Caputo TA, Kent KC, Salemi A, Krieger KH, Goldstein MJ, Kuo DY, Slomovitz BM. Worley MJ Jr, et al. Among authors: kuo dy. Am J Obstet Gynecol. 2009 Dec;201(6):574.e1-5. doi: 10.1016/j.ajog.2009.06.037. Epub 2009 Sep 2. Am J Obstet Gynecol. 2009. PMID: 19729144 Free PMC article.

5

Prevalence and factors associated with cognitive deficit in women with gynecologic malignancies.

Van Arsdale A, Rosenbaum D, Kaur G, Pinto P, Kuo DY, Barrera R, Goldberg GL, Nevadunsky NS. Van Arsdale A, et al. Among authors: kuo dy. Gynecol Oncol. 2016 May;141(2):323-328. doi: 10.1016/j.ygyno.2016.03.001. Epub 2016 Mar 14. Gynecol Oncol. 2016. PMID: 26946094

6

Delayed Presentation of Vaginal Cuff Dehiscence after Robotic Hysterectomy for Gynecologic Cancer: A Case Series and Review of the Literature.

Escobar PA, Gressel GM, Goldberg GL, Kuo DY. Escobar PA, et al. Among authors: kuo dy. Case Rep Obstet Gynecol. 2016;2016:5296536. doi: 10.1155/2016/5296536. Epub 2016 Mar 27. Case Rep Obstet Gynecol. 2016. PMID: 27110413 Free PMC article.

7

Unplanned hospitalizations in a racially and ethnically diverse population of women receiving chemotherapy for epithelial ovarian cancer.

Dioun S, Jorgensen JR, Miller EM, Tymon-Rosario J, Xie X, Xue X, Kuo DY, Nevadunsky NS. Dioun S, et al. Among authors: kuo dy. Gynecol Oncol. 2018 Oct;151(1):134-140. doi: 10.1016/j.ygyno.2018.08.021. Epub 2018 Aug 24. Gynecol Oncol. 2018. PMID: 30149897

8

Response to trametinib in recurrent low-grade serous ovarian cancer with NRAS mutation: A case report.

Champer M, Miller D, Kuo DY. Champer M, et al. Among authors: kuo dy. Gynecol Oncol Rep. 2019 Jan 31;28:26-28. doi: 10.1016/j.gore.2019.01.007. eCollection 2019 May. Gynecol Oncol Rep. 2019. PMID: 30809568 Free PMC article.

9

Reduced healthcare access contributes to delay of care in endometrial cancer.

Fife AJ, Najor AJ, Aspir TB, Haines KE, Vilardo NA, Isani SS, Cowan M, Gressel GM, Ye KQ, Nevadunsky NS, Kuo DY, Lin KY. Fife AJ, et al. Among authors: kuo dy. Gynecol Oncol. 2024 Mar;182:115-120. doi: 10.1016/j.ygyno.2024.01.010. Epub 2024 Jan 22. Gynecol Oncol. 2024. PMID: 38262233

10

Serous adenocarcinoma of the inguinal region arising from endometriosis followed by a successful pregnancy.

Slomovitz BM, Soslow RA, Chang RC, Golub R, Kuo DY. Slomovitz BM, et al. Among authors: kuo dy. Gynecol Oncol. 2002 Oct;87(1):152-4. doi: 10.1006/gyno.2002.6790. Gynecol Oncol. 2002. PMID: 12468359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters